In Taiwan, the post-market monitoring process ensures drug safety through pharmacovigilance and Periodic Safety Update Reports (PSURs). The TFDA tracks adverse events, conducts inspections, and may require further studies or labeling changes if new risks emerge. This continuous monitoring ensures that drugs maintain safety, efficacy, and quality throughout their lifecycle.
